Glaucoma, an eye disease that damages the optic nerve and can result in vision loss and blindness, can now be treated with a simple injection, eye surgeons have said.
XenIn glaucoma, eye pressure plays a role in damaging the optic nerve.
A new technology developed by a US-based company relieves the pressure in the eye with a minimally invasive method, thus doing away with the need for scalpels and stitches, the experts noted.
It involves using a hypodermic needle to inject a tiny pliable drainage tube into the eye, allowing excess fluid to flow out, the Daily Mail reported.
The Xen Gel Stent developed by California-based AqueSys Inc is six mm long and about the width of a human hair. It is injected through a small self-sealing corneal incision using a simple, preloaded injector.
It was “quicker and safer” than current methods, Vik Sharma, a consultant eye surgeon at the Royal Free Hospital in London, was quoted as saying.
But the XEN Gel Stent is an investigational device, which means it has not been approved by the US Food and Drug Administration (FDA) yet.
The current approach in the management of patients with glaucoma begins with medications followed by laser surgery, or trabeculectomy, a treatment that frequently involves installing a small rigid tube in the eye to drain it.
This is attached to a metal plate embedded below the eye, which helps draw the fluid away. The eye must be cut to insert these relatively bulky items, and stitched up again, which leads to a high complication rate.
By comparison, the Xen Gel Stent is delivered directly via a hypodermic needle into the eye which has potential to lower complications rate compared to traditional methods.
source: India Medical Times
With growing per capita healthcare expenditure both in developed and advanced developing countries, the mobile healthcare market is projected to reach $58.8 billion by 2020, at a CAGR (compound annual growth rate) of 32.3 per cent from 2013 to 2020, according to a report by Allied Market Research.
The report, titled ‘mHealth Market (Devices, Applications, Services and Therapeutics) — Global Mobile Healthcare Industry Size, Analysis, Share, Growth, Trends and Forecast, 2012–2020’, observed that the global mHealth market was valued at $6.7 billion in 2012 and is estimated to reach $8.3 billion by the end of 2013.
“Per capita expenditure on healthcare in developed economies is increasing at a faster rate than inflation and income levels, chiefly due to ageing population and chronic diseases which are lifestyle driven,” note Allied Market Research analysts James Franco and Yojana Jeevane. “However, there has not been corresponding improvement in the quality of healthcare services delivered, especially in developing regions. Additionally, developing economies are even struggling to provide healthcare access at every level to their people.”
On contrary, ubiquitous access of smart mobile devices globally has enabled diagnostic and monitoring devices to render seamless healthcare services. Thus, this market is expected to grow at a significant pace in the next seven years. This projection is backed by the fact such as due to technological advancement integration of wireless technology with the portable healthcare devices is feasible, increasing incidences of lifestyle diseases, cost and convenience factors, government initiatives, affordability of smartphones.
However, weak reimbursement policies, lower adoption due to lack of accuracy and technology infancy and uncertainty in the government regulations is expected to hinder the growth rate. Moreover, untapped markets in developing economies provide a lot of growth opportunities for this market due to increase in adoption of mHealth services to control the spread of communicable as well as non-communicable diseases. Such challenges can be very well taken by adoption of mHealth devices and services as they work irrespective of location and skilled professionals. The only mandatory requirement is the mobile access and a smartphone.
This report segments the global mHealth Market on the basis of devices, services, stakeholders, and therapeutic areas. The global mHealth devices market is forecast to reach market value of over $1.5 billion in 2013 from $0.8 billion in 2011. The contributory factors for this growth is high revenue generated from blood glucose meters, cardiac monitors and BP monitors in descending order. The services market is projected to grow over $6 billion by 2013 from 2011 market values of $4 billion mainly due to increase in revenues generated from monitoring and diagnostic services. In stakeholders market study mobile operators as well as device vendors will account for more than 75 per cent of the overall market share by 2020.
The geography market assessment signifies that Europe along with North America will account for about 55 per cent of the overall market revenue in 2013 and may reduce with growing demand in Asia Pacific region. The study also offers an updated review on the present major market player such as manufacturers of mobile medical devices, and mobile network providers; which also includes description of relevant recent developments activities. Companies profiled in the report includes Philips Healthcare, Omron HealthCare, Bayer Healthcare, LifeWatch, Cardionet, Masimo Corporation, Sanofie, Boston Scientific, AT&T, and Johnson & Johnson.
A biotechnology company developing an unusual drug—derived from the venom of a sea anemone to treat autoimmune diseases such as psoriasis and multiple sclerosis—reported encouraging results from a phase 1 clinical trial.
Seattle-based Kineta Inc. said it expects early next year to begin recruiting patients for the next stage of the drug’s development, a phase 2 clinical trial. Kineta said the drug, called dalazatide, is intended to block only the white blood cells that cause many autoimmune diseases. Traditional treatments for autoimmune disorders suppress the entire immune system, putting patients at risk for infections.
Phase 1 trials are preliminary, meant to test the safety and tolerability of a new drug in a small group of patients. The bulk of new drugs tested fail to advance to phase 2 trials, which test a product’s efficacy among a larger group.
Autoimmune diseases affect as many as 23.5 million people in the U.S., especially women, according to the National Institutes of Health. Prevalence of the diseases, in which the immune system attacks the body’s own organs, tissues and cells, is increasing, for reasons that aren’t clear. There is no cure.
“The results of this trial indicate an important advance in developing next-generation treatments for autoimmune disease that specifically regulate the immune response without broad immune suppression,” said Dr. Shawn Iadonato, Kineta’s chief scientific officer.
Source: fox news
The mere thought of sneaking out for a lunchtime yoga class may be laughable, especially now that we’re all asked to do more and more on the job. But that doesn’t mean you have to stay stagnant for hours. There are effective moves you can do right at your desk, ones that will help you get a mental breather and make sure your neck, back, arms, hips and wrists remain in good working order.
Sit at the edge of your chair, press your hands down on either side of your hips and raise your legs and butt up off the seat. Engage your deep abdominal muscles and keep the tops of your shoulders down; hold for 3 to 5 breaths. Lower and repeat 2 more times
2. High Altar Pose
Inhale and lift your arms; clasp your hands and invert your palms. Lean to your left. Hold for 5 to 8 breaths, then switch sides.
Turn to your left. Use your left hand on the back of the chair to deepen the twist. Hold for 5 to 8 breaths, then twist to the other side.
4. Cow Face Arms
Bring your left arm behind your back and right arm behind your head. Clasp fingers if you can. Hold for 5 to 8 breaths; switch sides.
5. Ankle to Knee
Place your left foot on your right knee, letting left knee drop open. Keep your back straight; lean forward to stretch deeper. After 5 to 8 breaths, switch sides
Autism is a neurodevelopmental disorder that affects the normal brain’s function. The condition makes a person hard to communicate with and relate to other people.
The disease is part of the autism spectrum and therefore is sometimes referred to as an autism spectrum disorder, or an ASD. It is believed that symptoms occur in the first two years of an individual’s life and the condition remains with the person for his/her whole life.
The disease affects children of all races, both boys and girls in all geographic regions, and is on the rise. In India, it is said that about 10 million people have been affected with autism.
In order to create awareness about the disease, World Autism Awareness Day is observed on 2 April every year since 2008. Since then, the Autism Day has been celebrated with specific fundraising and awareness-raising events every year.
It is not known what causes autism, however, many researchers believe genetics is 90% responsible of the risk of a child getting autism. Some cases are linked to chemical exposure during pregnancy.
Symptoms may include – impairments in social interaction, impairments in communication, restricted interests and repetitive behaviour. Symptoms and severity may also differ for each child in each of the affected areas.
Also, parents often observe that their child with autism avoids eye contact with others and prefers to play alone. It is found that majority of the children with autism have below-normal intelligence, and teenagers with the condition often suffer from depression and anxiety.
Also, some of the autistic kids develop seizure disorder like epilepsy as they enter their teens. Parents should seek timely medical help if their child develops symptoms similar to ASD. While the symptoms related to autism can also be linked with other developmental disorder, early treatment can make a big difference.
Coping and support
- For parents, caring for a child with autism can be physically, emotionally challenging.
- But, it is important for parents to learn about the disorder as this will help them better understand their child.
- Talking to other families of children with ASD may provide useful tips and advice in caring for an autistic kid.
- Also, apart for medical care, parents should keep themselves updated with latest technologies and therapies.
Autism cannot be cured, but it can be treated and children can improve their language and social skills.
Since some cases are linked to chemical exposure during pregnancy, it is recommended to avoid alcoholic beverages, drugs during pregnancy. Also, getting immunized against German measles (rubella) prior to pregnancy can prevent rubella-associated autism.
Source: Zee news